Taken together with our previous study [5], we have now identified four discrete mechanisms of crosstalk between HIF-1α and TAZ that serve to increase the activity of both pathways (Figure 6) and drive breast cancer progression [5]. The gene discussed is HIF1A; the disease is breast cancer.